Exelixis | EXEL - درآمد حاصل از بهره

قیمت سهام
41.27
تغییر روزانه
0.01 0.02%
ماهیانه
-6.23%
سالیانه
11.66%
Q1 پیش بینی
40.03




درآمد حاصل از بهره تغییر دادن تاریخ
Acadia Pharmaceuticals USD 8.25M 1M 2025-09
Agios Pharmaceuticals USD 13.37M 1.14M 2025-09
AstraZeneca USD 85M 17M 2025-09
Bayer EUR 130M 38M 2025-09
BioMarin Pharmaceutical USD 17.85M 973K 2025-09
Cytokinetics USD 10.25M 2.75M 2025-09
Eisai JPY 3.11B 783M 2024-03
Eli Lilly USD 65M 25M 2025-09
Esperion Therapeutics USD -0.15 0.18 2024-09
Exelixis USD 15.92M 867K 2025-09
Genmab DKK 25M 8M 2025-06
Glaxosmithkline GBP 26M 24M 2025-09
Incyte USD 30.75M 3.97M 2025-12
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
MacroGenics USD 1.53M 114K 2025-09
Merck USD 96M 27M 2025-09
Moderna USD 73M 8M 2025-09
Nektar Therapeutics USD -0.18 0.07 2024-09
Pfizer USD 0.62 156M 2025-09
Puma Biotechnology USD 0.41 0.5 2024-09
Sanofi EUR 114M 38M 2025-09
Takeda JPY 87.87B 43.48B 2025-12
Ultragenyx Pharmaceutical USD 5.86M 69K 2025-09
Xencor USD 6.54M 710K 2025-09